ORPHA:213828
Adenoid basal carcinoma of the cervix uteri
Also known as: Cervical adenoid basal carcinoma
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
16
26.3th percentile
Trials
0
Interventional, condition-specific
Researchers
89
Distinct authors in sample
Gene link
—
Readiness
1/6
Stages with a signal
Clinical definition (Orphanet)
A rare, slow-growing uterine cancer characterized, histologically, by small, well differentiated nests of basaloid cells resembling basal cell carcinoma of the skin, commonly associated with squamous cell carcinoma or squamous intraepithelial lesions. Patients are usually asymptomatic or present with dysfunctional vaginal bleeding, often with no observable lesion on the cervix. Infection with high-risk HPV-types (16 and 33) has been reported in some cases.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0016287
- MONDO:0006132
- UMLS:C1516403
- NCIT:C40213
Additional Mondo synonyms (5)
adenoid basal carcinoma of the cervix uteri · cervical adenoid basal cancer · cervical adenoid basal carcinoma · skin adenoid basal cell carcinoma of uterine cervix · uterine cervix skin adenoid basal cell carcinoma
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
1/6 stages with a signal
Research-stage checklist from open sources (GenCC, literature, Monarch when enriched, ClinicalTrials.gov). Not a prognosis or care recommendation.
- Gene identifiedNot found
No GenCC disease–gene assertion in this build
- LiteraturePresent
16 matched papers (9 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Not yet — the cause hasn't been pinned down in GenCC.
No strong gene–disease assertion joined for this Orphanet entity.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
16
16 papers have ever been indexed under this name. For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
16 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
9 in the last 10 years · high confidence · 26.3th percentile (publications denominator)
Phrase hits: 16 · MeSH hits: 0
Who's working on it?
89
Distinct author names in 16 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01McCluggage WG2 papers · 2024
Department of Pathology, Belfast Health and Social Care Trust, Belfast, United Kingdom.
Papers in Europe PMC - 02Ackroyd S1 paper · 2024
University of Chicago, Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, United States.
Papers in Europe PMC - 03Allard U1 paper · 2002Papers in Europe PMC
- 04Argon A1 paper · 2012
Clinic of Medical Pathology, Ministry of Health İzmir Bozyaka Training and Research Hospital, İzmir, Turkey.
Papers in Europe PMC - 05Bernabé SR1 paper · 2023
Medical Oncology, Clinica Universidad de Navarra, Pamplona, Spain.
Papers in Europe PMC - 06Centeno C1 paper · 2023
Department of Palliative Medicine, University of Navarra, Pamplona, Spain.
Papers in Europe PMC - 07Chargari C1 paper · 2023
Service d'Oncologie Radiothérapie, Hôpital Universitaire Pitié Salpêtrière, Paris, France.
Papers in Europe PMC - 08Chen J1 paper · 2025
Cervical disease diagnosis and treatment health center, Fujian Maternity and Child Health Hospital College of Clinical Medical for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, 18 Daoshan Road, Fuzhou, Fuzhou, 350001, China. chenjc928@163.com.
Papers in Europe PMC - 09Chen Y1 paper · 2025
Cervical disease diagnosis and treatment health center, Fujian Maternity and Child Health Hospital College of Clinical Medical for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, 18 Daoshan Road, Fuzhou, Fuzhou, 350001, China.
Papers in Europe PMC - 10Cibula D1 paper · 2023
Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University, Prague, 121 08, Czech Republic. dc@davidcibula.cz.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Adenoid basal carcinoma of the cervix uteri" OR "Adenoid basal carcinoma of cervix uteri" OR "Cervical adenoid basal carcinoma" OR "cervical adenoid basal cancer" OR "skin adenoid basal cell carcinoma of uterine cervix" OR "skin adenoid basal cell carcinoma of the uterine cervix" OR "uterine cervix skin adenoid basal cell carcinoma"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Adenoid basal carcinoma of the cervix uteri" OR "Adenoid basal carcinoma of cervix uteri" OR "Cervical adenoid basal carcinoma" OR "cervical adenoid basal cancer" OR "skin adenoid basal cell carcinoma of uterine cervix" OR "skin adenoid basal cell carcinoma of the uterine cervix" OR "uterine cervix skin adenoid basal cell carcinoma" OR "skin adenoid basal cell carcinoma"
Recall-expansion terms: skin adenoid basal cell carcinoma
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T09:40:12.153Z